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The purpose of the present study was to clarify the possible relationship between nitro-
glycerin (NTG)-induced headache and both vascular functional and organic atheros-
clerosis. The study included 96 patients with NTG-induced headache (group I: 54.7±9.5
years, 52 males) and 204 patients without headache (group II: 58.1±9.1 years, 127 
males) who suffered from new-onset chest pain. Flow-mediated dilation and nitro-
glycerin-mediated dilation were significantly greater in group I than in group II (8.8±
4.1% vs. 7.1±3.5%, p=0.001, and 23.1±7.3% vs. 17.1±11.8%, p＜0.001, respectively). 
The carotid intima-media thickness was significantly smaller in group I than in group 
II (0.55±0.15 mm vs. 0.67±0.22 mm, p=0.001). Heart-carotid pulse wave velocity was 
significantly lower in group I than in group II (784.5±160.1 m/s vs. 979.1±215.6 m/s, 
p=0.003). In the multiple regression analysis, the absence of NTG-induced headache 
was a predictor of coronary artery disease (CAD) (odds ratio: 17.89, 95% confidence in-
terval: 7.89-40.02, p＜0.001). NTG-induced headache developed more frequently in pa-
tients with normal coronary arteries or minimal CAD than in patients with obstructive 
CAD. The presence of NTG-induced headache might be helpful and provide additional 
information in evaluating patients with chest pain syndrome.
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INTRODUCTION
　Nitroglycerin (NTG)-induced headache is the most pro-
minent side effect of nitrate therapy in patients with chest 
pain. Much work has been published regarding the role of 
increased nitric oxide (NO) in migraine subjects during 
acute migraine attacks.
1-3 Intracranial arteries are dilated 
during migraine attack to increase intracranial flow, and 
when the migraine attack has subsided, intracranial flow 
returns to the baseline level.
4-6 The capacity of blood vessels 
to respond to NO donors in the lumen confers the ability 
to self-regulate vascular tone and to adjust blood flow and 
distribution in response to changes in the local environ-
ment, indicating that NO may play a key role in migraine. 
　Therefore, we hypothesized that patients with NTG-in-
duced headache have preserved vascular smooth muscle 
function and would show an increased response to NTG-in-
duced dilation (NMD) in the brachial artery. However, there 
are few published data evaluating the association between 
NTG-induced headache, angiographic coronary artery dis-
ease (CAD), and noninvasive measurements of atheroscle-
rosis in patients with chest pain. Therefore, the aim of this 
study was to clarify the possible relationship between NTG- 
induced headache and both vascular functional and organic 
atherosclerosis in patients with chest pain.
MATERIALS AND METHODS
1. Study population
　From September 9, 2007, to September 9, 2009, the study 
included 300 patients who were scheduled for coronary an-
giography at Chonnam National University Hospital be-
cause of new-onset chest pain. Patients were divided into 
two groups according to the presence or absence of NTG-in-15
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duced headache: 96 patients with NTG-induced headache 
(group I: 54.7±9.5 years, 52 males) and 204 patients with-
out NTG-induced headache (group II: 58.1±9.1 years, 127 
males). Patients were excluded from this study if they had 
a history of chronic headache and migraine; use of nitrates 
for more than 3 months; previous myocardial infarction, 
heart failure, or other serious diseases; or former coronary 
angiography. Coronary angiography was performed with-
in 1 month after NTG administration with the usual clin-
ical indications. 
2. Methods
　1) Nitroglycerin-induced headache:  After the sublingual 
administration of 0.6 mg NTG for NTG-mediated submaxi-
mal vasodilation, the presence of NTG-induced headache 
was determined according to the criteria proposed by the 
International Headache Society
7: A. Headache with at least 
one of the following characteristics and fulfilling criteria 
C and D: 1) bilateral, 2) frontotemporal location, 3) pulsating 
quality, 4) aggravated by physical activity, B. Absorption 
of an NO donor, C. Headache develops within 10 minutes 
after absorption of NO donor, D. Headache resolves within 
1 hour after release of NO has ended.
7 Flow- mediated dila-
tion (FMD), NMD, and inflammatory and coagulation mar-
kers were measured early in the morning after the patients 
had fasted overnight for more than 12 hours.
　2) Measurement of endothelial function:  FMD of the bra-
chial artery was measured as the noninvasive parameter 
of endothelial function according the guideline
3 described 
previously. Vasoactive therapies were not prescribed for at 
least 24 hours before the study until the measurement was 
completed except for short-acting sublingual NTG, which 
was withheld for 1 hour before the study.
　All studies were performed early in the morning (0600- 
0800 hours) before coronary angiography, by use of an 8 
MHz high-resolution lineal vascular ultrasound trans-
ducer (Acuson Sequoia 512; Siemens Medical Solutions, 
USA), which was used to image the brachial artery longi-
tudinally just above the antecubital fossa. A tourniquet for 
measuring blood pressure was placed on the lower arm to 
create shear stress induced by reactive hyperemia. After 
baseline measurements of the brachial artery diameter, 
the blood pressure cuff was inflated to at least 50 mmHg 
above systolic blood pressure to occlude arterial flow for 5 
minutes. Subsequent deflation of the cuff induces a brief 
high-flow state through the brachial artery (reactive hy-
peremia) to accommodate the dilated resistance vessels. 
The resulting increase in shear stress causes the brachial 
artery to dilate. The brachial artery was imaged for the first 
2 minutes of reactive hyperemia continuously. The flow- 
mediated dilatory response was used as a measure of endo-
thelial-dependent dilation. After 10 minutes of rest to rees-
tablish the baseline condition, 0.6 mg of NTG was admini-
stered sublingually. The brachial artery was imaged for 10 
minutes continuously to measure peak diameter. NMD was 
used as a measure of endothelial-independent dilation. All 
patients were asked about NTG-induced headache after 
sublingual administration. In this studies, the intra- and 
inter-observer variability for the repeated measurements 
of resting arterial diameter were excellent (r=0.997, p＜ 
0.001, and r=0.997, p＜0.001).
　3) Carotid artery evaluation by B-mode ultrasound: The 
carotid intima-media thickness (IMT) was measured in the 
left and right common carotid arteries by use of high-reso-
lution B-mode ultrasound (Acuson Sequoia 512; Siemens 
Medical Solutions, USA) with an electric linear transducer 
(mid frequency 8.0 MHz). Each IMT was determined for the 
far wall of both common carotid arteries. The common car-
otid artery was studied in the longitudinal plane from the 
level of the common carotid artery. The images were re-
corded from the approach showing the greatest distance be-
tween the lumen-intima interface and the media-adven-
titia interface. All scans were recorded on super-VHS vid-
eotape for subsequent analysis. The IMT was measured 
from the B-mode screen to within 10 mm proximal to the 
bifurcation and synchronized with the R-wave peak by one 
investigator who was blinded to the patient characteristics. 
The mean IMT was calculated as the mean of 10 measure-
ments using electronic calipers. In the studies presented 
here, the intra- and inter-observer variability for the repea-
ted measurement of IMT were 0.08±0.001 mm and 0.13± 
0.002 mm, respectively.
　4) Pulse wave velocity evaluation: We used heart-carotid 
pulse wave velocity (PWV) and brachial-ankle PWV as the 
index for atherosclerosis. A medical technician measured 
the PWV and blood pressure of each subject twice by using 
a brachial-ankle PWV/ABI device (Nippon Colin, Aichi, 
Japan) while the subject was at rest in a supine position. 
This device, approved by the US Food and Drug Admini-
stration as VP-2000/1000, can monitor bilateral brachial 
and ankle pressure wave forms simultaneously by using 
the volume plethysmographic method, with two optional 
tonometry sensors for carotid and femoral arterial wave 
measurements. The medical technicians practiced PWV 
measurements beforehand and made arrangements for 
standardization.
　5) Diagnostic coronary angiography: No anti-anginal 
therapy was prescribed for at least 24 hours before cathe-
terization, except for the unrestricted use of sublingual 
NTG. The coronary arteries were divided into segments ac-
cording to the American Heart Association classification. 
Coronary angiograms were analyzed with a validated quan-
titative coronary angiography (QCA) system (Philips H5000 
OR Allura DCI program; Philips Medical Systems, Eindhoven, 
The Netherlands). With the outer diameter of the contrast- 
filled catheter as the calibration standard, the minimal lu-
men diameter and reference diameter were measured in 
diastolic frames from orthogonal projections. Obstructive 
CAD was defined as significant if the mean lumen diameter 
reduction was ≥50% in any of the major coronary arteries. 
　6) Assessment of vascular risk factors: Diabetes mellitus 
was defined as receiving oral hypoglycemic agents or in-
sulin to lower blood glucose levels or known fasting blood 
glucose values of ≥126 mg/dL or postprandial 2-hour blood 16
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TABLE 1. Baseline clinical characteristics of the study groups
Group I 
(n=96)
Group II 
(n=204)
p value
Age (years) 54.7±9.5 58.1±9.1 　0.003
Male, n (%) 52 (54.2) 127 (62.1) 　0.208
Body mass index (kg/m
2) 25.1±4.0 24.3±4.8 　0.211
Waist circumference (cm)   87.1±10.3 88.0±8.3 　0.523
Risk factors       
　Smoking, n (%) 33 (34.4) 63 (31.0) 　0.597
　Hyperlipidemia, n (%) 11 (11.6) 26 (14.1) 　0.710
　Hypertension, n (%) 30 (31.3) 83 (41.1) 　0.125
　Diabetes mellitus, n (%) 14 (14.6) 33 (16.5) 　0.736
　Family history, n (%) 1 (1.0) 7 (3.5) 　0.445
Medication 26 (29.8) 41 (37.6) 　0.290
　β-blockers, n (%) 13 (14.9) 15 (13.7) 　0.840
　CCB, n (%) 1 (1.1) 4 (3.6) 　0.385
　ACE inhibitors, n (%) 11 (12.6) 19 (17.4) 　0.427
　Statins, n (%) 26 (29.8) 41 (37.6) 　0.290
　Nitrates, n (%) 13 (14.9) 15 (13.7) 　0.840
Coronary angiography 
finding, n (%)
＜0.001
　DS＜50% 84 (87.4) 80 (34.3)
　DS≥50% 12 (12.6) 124 (65.7)
Values are presented as numbers (%) or mean±standard deviation.
CCB: calcium channel blocker, ACE: angiotensin-converting en-
zyme, DS: diameter stenosis.
TABLE 2. Flow-mediated dilation, nitroglycerin-mediated dila-
tion, carotid intima-media thickness, brachial-ankle pulse wave
velocity, systolic blood pressure, and diastolic blood pressure in 
the two groups
Group I 
(n=96)
Group II 
(n=204)
p value
Brachial basal 
diameter (mm)
  3.8±0.6   4.0±0.6 　0.028
FMD (%)   8.8±4.1   7.1±3.5 　0.001
NMD (%) 23.1±7.3   17.1±11.8 ＜0.001
Carotid IMT (mm)   0.55±0.15   0.67±0.22 　0.001
Hc PWV (cm/sec)   784.5±160.1   979.1±215.6 　0.033
Ba PWV (cm/sec) 1,483.6±242.9 1,594.1±266.5 　0.031
Systolic blood 
pressure (mmHg)
127.1±13.3 128.8±15.4 　0.366
Diastolic blood 
pressure (mmHg)
80.0±9.2   79.9±10.9 　0.915
Values are presented as numbers (%) or mean±standard deviation.
FMD: flow-mediated dilation, NMD: nitroglycerin-mediated dila-
tion, IMT: intima-media thickness, Hc PWV: heart-carotid pulse
wave velocity, Ba PWV: brachial-ankle pulse wave velocity.
glucose values of ≥200 mg/dL. Hypertension was defined 
as receiving antihypertensive medications or known blood 
pressures of ≥140/90 mmHg. Dyslipidemia was defined as 
total cholesterol ≥220 mg/dL or low-density lipoprotein 
cholesterol ≥130 mg/dL. Smokers were defined as those 
who were smoking currently or had stopped smoking with-
in 3 months of enrollment in the present study.
　7) Laboratory measurements: We measured the blood 
levels of white blood cell (WBC) counts, monocyte counts, 
high-sensitivity C-reactive protein (hs-CRP), and fibri-
nogen to examine the coagulation system. Blood samples 
were taken by venipuncture in the morning from patients 
after they had fasted for ＞12 hours before angiography. 
Hs-CRP was measured by immunoturbidimetric CRP- 
Latex (II) assay by using an Olympus AU 5400. Measure-
ment of fibrinogen was performed by chromogenic assay 
(Sysmex, CA1500, Mundelein, IL, USA). 
　8) Statistical analysis: Data for the categorical variables 
are expressed as both the number and the percentage of pa-
tients. For continuous variables, data are expressed as the 
mean±SD. Independent sample t-test was used to compare 
variables between the two groups. Comparison between 
different groups was made by using the chi-square test for 
categorical variables. Multivariate logistic regression 
analysis was performed to identify independent predictors 
of CAD. A p value＜0.05 was considered indicative of stat-
istical significance. All statistical calculations were per-
formed with a commercially available statistical software 
package (SPSS, version 15.0; SPSS Inc, Chicago, IL, USA).
RESULTS
1. Patient characteristics
　The clinical characteristics including the risk factors of 
the study population are shown in Table 1. Age was signifi-
cantly greater in group II than in group I. However, there 
were no significant differences in gender, risk factors, blood 
pressure, or medications between the two groups. 
　Hs-CRP, fibrinogen, and homocysteine levels were not 
significantly different between the two groups. The level 
of triglyceride was significantly lower in group I than in 
group II. 
2. Flow-mediated dilation, NTG-mediated dilation, and 
pulse wave velocity
　The data on brachial diameter, FMD, and NMD are shown 
in Table 2. The mean brachial basal diameter was signifi-
cantly smaller in group I than in group II. The mean FMD 
was significantly higher in group I than in group II. The mean 
NMD was significantly greater in group I than in group II.
　The data on the mean carotid IMT, the mean heart-car-
otid PWV (hcPWV), and the mean brachial-ankle PWV 
(baPWV) are shown in Table 2. The mean carotid artery 
IMT was significantly smaller in group I than in group II. 
The mean hcPWV and the mean baPWV were significantly 
lower in group I than in group II (Table 2).
3. Nitroglycerine-induced headache in patients with or 
without coronary artery disease
　One hundred sixty-four patients had normal coronary 
arteries or minimal coronary artery disease. One hundred 
thirty-six patients had obstructive CAD with greater than 
50% luminal diameter narrowing in one or more of the left 
or right coronary arteries or their major branches. In pa-17
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TABLE 3. Independent predictors of coronary artery disease by multivariate regression analysis
 OR 95%  CI p  value
Absence of nitroglycerin-induced headache 17.89   7.89-40.02 ＜0.001
Low-density lipoprotein cholesterol   9.25   1.77-17.44 　0.050
Heart-carotid pulse wave velocity (≥880 cm/s)    6.48   1.34-11.60 　0.056
Nitroglycerin-mediated dilation (≤20%)   0.80 0.01-1.66 　0.092
Age≥65 years   1.01 0.89-2.02 　0.213
Carotid intima-media thickness (≥0.65 mm)   1.31 0.04-2.57 　0.331
Triglyceride   4.05 0.43-7.81 　0.336
Flow-mediated dilation (≤8%)   4.01 0.22-8.11 　0.533
Female   1.10 0.22-2.25 　0.675
Adjusted for body mass index, smoking status, diabetes mellitus, and family history. OR: odds ratio, CI: confidence interval.
tients with normal coronary arteries or minimal CAD, 87.4% 
reported significant episodes of headaches after NTG use 
compared with only 12.6% of patients with obstructive CAD 
(p＜0.001) (Table 1).
4. Independent predictors of coronary artery disease
　We performed multivariate analysis to determine in-
dependent predictors of coronary artery disease. The fol-
lowing variables were tested (all with p＜0.2 in univariate 
analysis): age, hypertension, diabetes mellitus, smoking, 
HDL-cholesterol, triglyceride, NTG-induced headache, 
FMD, NMD, carotid IMT, and hcPWV. The absence of 
NTG-induced headache (odds ratio: 17.89, 95% confidence 
interval: 7.89-40.02, p＜0.001) was the only independent 
predictor of CAD (Table 3).
DISCUSSION
　The present study demonstrated that 1) patients with 
NTG-induced headache had greater NMD and FMD in the 
brachial artery, smaller carotid IMT, and lower PWV than 
did patients without NTG-induced headache; 2) NTG-in-
duced headache developed more frequently in patients 
with normal coronary arteries or minimal CAD than in pa-
tients with obstructive CAD; 3) and the absence of NTG-in-
duced headache was an independent predictor of CAD. 
　There are conflicting reports regarding the relationship 
between a history of migraine headaches and angina and 
between migraine headaches and cardiovascular events 
such as myocardial infarction and stroke. Although multi-
ple population-based studies have found that patients with 
migraine headaches are more likely to have chest pain 
symptoms,
8-11 the reported association between migraine 
headaches and major cardiovascular events has been in-
consistent. 
　One large study observed a relationship between migraine 
headaches and cardiovascular events in a community-based 
of population of 3654 Australian men and women and noted 
that subjects with migraine headaches were twice as likely 
to have a self-reported history of myocardial infarction.
12 
Conversely, findings from the more recent prospective 
Nurses’ and Physicians’ Health Studies failed to show an 
association between migraine headaches and verified car-
diovascular events, including angina and myocardial in-
farction.
13 A possible explanation for these discrepant fin-
dings may include the reliance on self-reported cardiovas-
cular events. Studies that used verified events data have 
consistently highlighted an absence of an association be-
tween migraine headaches and cardiovascular events.
14 
　In the present study, NTG-induced headache developed 
more frequently in patients with normal coronary arteries 
or minimal CAD than in patients with obstructive CAD by 
coronary angiography. Nitrates can dilate epicardial coro-
nary arteries and collateral vessels in patients with obstruc-
tive CAD.
15,16 The prevalence of carotid atheromatous pla-
que was highly correlated with that of CAD, and carotid 
vascular elasticity to NTG use was decreased in patients 
with severe CAD.
17 Therefore, NTG-induced headache might 
occur less frequently in patients with atherosclerosis. 
　The vascular endothelium has been reported to be a mul-
tifunctional component whose integrity is essential for nor-
mal vascular physiology. Loss of adequate endothelial cell 
function is most widely quantified by assessing FMD and 
NMD. Previously, we reported that decreased FMD and in-
creased carotid IMT and PWV were associated with CAD.
18 
In particular, the dilatory response to NTG is used as a mea-
sure of endothelium-independent vasodilation. The vaso-
dilator response to NTG is impaired in the brachial artery 
of patients with CAD, which illustrates functional abnor-
malities in smooth muscle dilation in adults with athe-
rosclerosis.
19,20 However, there is strong and growing evi-
dence that abnormalities in endothelial function are pres-
ent before the development of angiographically evident 
coronary atherosclerosis in patients with coronary risk 
factors.
21-24 Previous studies suggested that the increasing 
arterial stiffness may relate to early endothelial dysfunc-
tion and overt atherosclerosis.
19,20 The results of the pres-
ent study, which showed that the absence of NTG-induced 
headache is an independent predictor of CAD, are con-
sistent with the findings of these studies. To the best of our 
knowledge, this study is the first to assess the arterial stiff-
ness of patients with chest pain by means of NTG-induced 
headache and to compare this method with other techni-
ques used to evaluate coronary artery stenosis, endothelial 18
Nitroglycerin-Induced Headache
dysfunction, and atherosclerosis, such as carotid IMT and 
PWV. The identification of NTG-induced headache is a 
simple and inexpensive way of assessing vascular function 
and may be used to screen patients for early detection of 
coronary artery disease. 
　There are several limitations to be mentioned. First, in 
order to evaluate endothelial function, organic atheroscle-
rosis, and arterial stiffness, the data obtained from the 
study subjects must be compared with those from a control 
group. The major limitation of this study is the lack of con-
trol data for comparison. Second, the sample size was rela-
tively modest. Therefore, further study is needed with a 
larger number of subjects. Further studies are also needed 
to establish the exact mechanisms of NTG-induced head-
ache in patients with chest pain, to investigate other mark-
ers of endothelial dysfunction, and to examine the potential 
role of smooth muscle function as an aid to risk-stratifying 
patients with NTG-induced headache. Third, we did not 
measure how many patients with NTG-induced headache 
experienced aura. Patients with NTG-induced headache 
with aura have been shown to be a group at slightly in-
creased risk for vascular events like ischemic stroke.
25 Our 
study was unable to explore this association. Previously, 
several clinical and hemodynamic studies using nitrate 
were published in Korea.
18,26-29 However, the clinical im-
pact and mechanisms are not exactly known. Fourth, the 
origins of chest pain in our study patients have not been 
determined, although it is possible that the patients had 
coronary artery spasm. Previous studies
7,8 showed that 
coronary vasospasm is closely related to atherosclerotic 
coronary artery disease. It is common for vasospasm to oc-
cur in lesions with angiographically normal or nearly nor-
mal coronary arteries. In the present study, provocative 
tests for coronary artery spasm using acetylcholine or ergo-
novine were not used. The number of patients who had coro-
nary artery spasm remained unknown, and the possible re-
lation between coronary artery spasm and NTG-induced 
headache was not determined. Further studies should be 
considered to ascertain the role of NTG-induced headache 
in patients with mild coronary artery stenosis and vaso-
spasm. 
　In conclusion, the results of the present study show that 
NTG-induced headache is associated with increased NMD 
and FMD in patients with chest pain. NTG-induced head-
ache developed more frequently in patients who had nor-
mal coronary arteries or minimal CAD than in patients 
with obstructive CAD. The presence of NTG-induced head-
ache might be helpful and provide additional information 
in evaluating patients with chest pain syndrome.
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